Example: Heart Attack

Search clinical trials for: Fludarabine

Total 1632 results

NCT02514083

Active, not recruiting

A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL

Conditions: Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
NCT01472055

Unknown status

Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation

Conditions: Acute Leukemia; Chronic Leukemia; Severe Aplastic Anemia
NCT04425655

Not yet recruiting

Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.

Conditions: Acute Myeloid Leukemia, Adult; AML; AML, Adult
NCT02926586

Unknown status

Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML

Conditions: Acute Myeloid Leukemia; Core-Binding Factor
NCT03754933

Recruiting

Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

Conditions: Recurrent Head and Neck Cancer
NCT00278265

Terminated

Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia

Conditions: T-Cell Large Granular Lymphocytic Leukemia
NCT02024308

Unknown status

AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy

Conditions: Acute Myeloid Leukemia; AML1-ETO Fusion Protein Expression
NCT00502905

Completed

Busulfan and Fludarabine in Patients With AML and MDS

Conditions: Leukemia
NCT03696537

Active, not recruiting

IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT

Conditions: Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndromes
NCT01019317

Completed

Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Conditions: Leukemia; AML; MDS; CML
NCT01310179

Completed

Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors

Conditions: Head and Neck Cancer
NCT00572897

Completed

Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis

Conditions: Myelofibrosis
NCT00506857

Completed

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Conditions: Hematologic Malignancies
NCT00208975

Terminated

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab

Conditions: Lymphoma
NCT02128945

Completed

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies

Conditions: Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
NCT00625430

Unknown status

A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer

Conditions: Prostate Cancer
NCT03832127

Not yet recruiting

Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients

Conditions: Myeloma
NCT00815568

Unknown status

Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)

Conditions: AML; MDS; ALL; CML; Lymphoma
NCT00004246

Completed

Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx

Conditions: Head and Neck Cancer
NCT00206726

Completed

Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)

Conditions: Leukemia, Lymphocytic, Chronic, B-Cell
NCT01814475

Completed

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

Conditions: Myelofibrosis
NCT00086580

Completed

Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients

Conditions: B-Cell Chronic Lymphocytic Leukemia
NCT02718755

Withdrawn

Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies

Conditions: Hematologic Malignancy
NCT01366612

Active, not recruiting

PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation

Conditions: Myeloid Malignancies; Acute Myelogenous Leukemia; Chronic Myelogenous Leukemia; Myeloproliferative Disorders; Myelodysplastic Syndrome
NCT03342196

Recruiting

Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation

Conditions: Leukemia